TFL ABC LIMITED
Company number 03675700 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: TFL ABC LIMITED
1. Financial Health Score: A
Explanation: This business exhibits the financial equivalent of a peak-condition athlete — robust reserves, strong growth momentum, excellent liquidity, and a manageable debt burden that is actively being reduced year over year. The trajectory over the past decade shows consistent, accelerating wealth accumulation with no symptoms of financial distress.
2. Key Vital Signs
| Vital Sign | 2025 Value | 2024 Value | Interpretation |
|---|---|---|---|
| Net Assets | £7,569,616 | £6,199,641 | Exceptional equity base; up 22.1% YoY |
| Total Assets | £11,522,562 | £10,388,957 | Substantial asset base growing steadily |
| Total Liabilities | £2,293,293 | £2,886,237 | Declining — healthy deleveraging |
| Cash at Bank | £1,158,060 | £472,902 | Strong cash reserves; up 145% |
| Net Current Assets | £2,477,891 | £1,872,237 | Excellent working capital buffer |
| Current Ratio | 3.67x | 3.20x | Highly liquid — well above 1.5x benchmark |
| Debt-to-Equity Ratio | 0.30x | 0.47x | Very low leverage; declining |
| Shareholders' Funds | £7,569,616 | £6,199,641 | Virtually all retained earnings — strong profit retention |
10-Year Net Asset Trajectory
| Year | Net Assets | YoY Growth |
|---|---|---|
| 2016 | £857,968 | — |
| 2017 | £890,333 | +3.8% |
| 2018 | £1,508,599 | +69.4% |
| 2019 | £1,938,516 | +28.5% |
| 2020 | £2,256,787 | +16.4% |
| 2021 | £2,626,666 | +16.4% |
| 2022 | £3,258,265 | +24.0% |
| 2023 | £5,430,501 | +66.6% |
| 2024 | £6,199,641 | +14.2% |
| 2025 | £7,569,616 | +22.1% |
Reading the chart: Net assets have grown approximately 8.8x over the decade, from £858k to £7.57M — an extraordinary compounding trajectory.
3. Diagnosis
Overall Condition: Robust Financial Health
Think of this business as a patient who started in fair condition and has progressively built exceptional physical fitness through disciplined habits and strategic investment.
a) Asset Strength — "Strong Musculoskeletal Frame"
The tangible asset base of £8.12M (predominantly land, buildings, and plant/machinery) represents the farm's structural backbone. This has grown from approximately £1.3M in 2017 to over £8.1M, reflecting significant capital investment in the core farming operation — likely land acquisition and infrastructure development. The minimal intangible assets (£nil) and small investment holding (£1,750) suggest the business is focused on real, productive assets rather than speculative positions.
b) Liquidity — "Excellent Cardiovascular Fitness"
The current ratio of 3.67x means the business has nearly £3.67 in short-term assets for every £1 of short-term obligations. This is well above the 1.5x threshold typically considered healthy. Cash has surged from £473k to £1.16M in a single year, indicating strong cash generation. The business can comfortably meet all near-term obligations with substantial headroom.
c) Leverage — "Low and Declining Cholesterol"
Total liabilities have fallen from £2.89M to £2.29M — a reduction of £593k (20.6%) in one year. The debt-to-equity ratio has dropped from 0.47x to 0.30x. This is the financial equivalent of a patient actively reducing cardiovascular risk factors. Long-term creditors of £2.29M against equity of £7.57M represents a very conservative capital structure.
d) Provisions — "Minor Watch Item"
Provisions increased from £454k to £734k — a £280k rise. This could relate to deferred tax provisions on revalued assets, environmental obligations, or other anticipated costs. While not concerning at this scale, it warrants monitoring to ensure these don't grow disproportionately.
e) Retained Earnings — "Exceptional Vitality Accumulation"
Share capital of just £40 against retained earnings of £7,569,576 tells us the business has generated virtually all its wealth through profitable trading rather than shareholder investment. This is the hallmark of a self-sustaining, profitable enterprise that reinvests its earnings effectively.
f) Strategic Repositioning — "Healthy Adaptation"
The recent name changes (Thomasson Farms → Thomasson Livestock → TFL ABC) between November 2025 and January 2026, combined with the website promoting BioBloom, an eco-friendly soil enricher, suggest the business is diversifying beyond traditional dairy farming. This strategic evolution appears well-supported by the strong financial position.
4. Recommendations
🟢 Continue: Current Growth Trajectory
The business is compounding wealth effectively. The 22% net asset growth year-over-year is exceptional for a farming operation. Continue disciplined reinvestment.
🟡 Monitor: Cash Volatility
Cash has fluctuated significantly — £1.59M (2023), £473k (2024), £1.16M (2025). This may reflect seasonal farming cycles or capital expenditure timing, but understanding the drivers is important for forecasting. Consider establishing a minimum cash reserve target.
🟡 Investigate: Rising Provisions
The £280k increase in provisions should be understood. If these relate to deferred tax on unrealised gains, this is normal. If they relate to environmental or operational liabilities, ensure adequate coverage.
🟢 Opportunity: Leverage the Balance Sheet for BioBloom
With debt-to-equity at just 0.30x and strong cash generation, the business has significant capacity to fund the BioBloom diversification from internal resources rather than taking on additional debt. This preserves financial flexibility.
🟡 Review: Working Capital Efficiency
Debtors of £1.33M against creditors of £0.93M suggests the business is effectively providing more credit to customers than it receives from suppliers. In a farming context, this may be normal (milk pool payments, etc.), but ensure this isn't creating unnecessary cash drag.
🟢 Maintain: Filing Compliance
Accounts and confirmation statements are up to date with no overdue filings. Continue this good governance practice.
Prognosis
The financial outlook for TFL ABC Limited is strongly positive. The business has demonstrated a decade-long track record of consistent wealth accumulation, with net assets growing at a compound annual growth rate of approximately 27% over the period. The declining leverage, strengthening liquidity, and substantial cash reserves provide both a defensive cushion against agricultural market volatility and an offensive platform for the BioBloom diversification strategy. The only cautionary notes are the rising provisions and cash flow variability, neither of which currently presents any material risk to financial stability.